[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 5 sources · 14 days · First seen · Last updated

BPA exposure and human insulin sensitivity research

Overview

Researchers from California Polytechnic State University and Rutgers University have conducted a randomized, double-blind clinical trial involving 40 young adults to investigate the effects of Bisphenol A (BPA) on human metabolism.

The study found that short-term oral administration of BPA, even at doses considered safe by the US Environmental Protection Agency (EPA) lifetime exposure threshold, resulted in a 9 percent decrease in peripheral insulin sensitivity. This finding provides direct experimental evidence in humans that BPA may impair insulin sensitivity, building upon previous animal and observational studies.

Lead author Todd Hagobian suggested that current exposure limits should be reconsidered and noted that switching to glass or stainless steel containers could potentially lower diabetes risk. While the FDA maintains that low levels of BPA in food packaging are safe, the study highlights the substance’s potential to disrupt hormones.

Entities

California Polytechnic State University · U.S. Environmental Protection Agency · Rutgers University · American Diabetes Association · Environmental Protection Agency

Timeline

  1. [HEALTH] 3 sources
    BPA exposure linked to reduced insulin sensitivity in human study

    A clinical study provides the first experimental evidence in humans that ingesting BPA, a common chemical in food packaging, can reduce insulin sensitivity even at doses currently deemed safe by the EPA.

  2. [HEALTH] 2 sources
    BPA exposure linked to reduced insulin sensitivity in new study

    A study from California Polytechnic State University suggests that BPA, even at currently approved safe levels, can reduce insulin sensitivity and increase the risk of type 2 diabetes.

Sources

haber7.com · medonet.pl · rynekzdrowia.pl · sciencealert.com · yenialanya.com